Skip to main content
. 2023 Apr 9;24(8):6964. doi: 10.3390/ijms24086964

Figure 1.

Figure 1

Structure of 3,2′-DHF and screening of several flavonoid treatments in WJ-MSCs. (A) Schematic illustration of therapeutic effects of Fla-EV. (B) Structure of 3,2′-dihydroxyflavone. (C) Comparison of time-dependent cell growth in several flavonoid treatment conditions derived from various sources.